Literature DB >> 34015554

N-acetylaspartate concentration in psychotic disorders: T2-relaxation effects.

Elliot Kuan1, Xi Chen1, Fei Du1, Dost Ongur2.   

Abstract

We used proton magnetic resonance spectroscopy (1H MRS) to quantify N-acetylaspartate (NAA) concentrations and apparent spin-spin (T2) relaxation times, which also include diffusion attenuations, in first episode and chronic psychosis patients compared to matched healthy controls. 104 patients diagnosed with psychotic disorders and 50 matched controls were scanned at 4 Tesla. 1H MRS data were collected at four echo times (TE = 30, 90, 150 and 200 ms) using PRESS. NAA concentrations referenced to water and apparent T2 relaxation times of NAA and water were calculated. At TE = 30 ms, NAA concentration without T2 correction was significantly lower in chronic psychosis patients compared to age-matched healthy controls (p = 0.013, N = 61 and 26, respectively) but normal in first episode patients compared to matched controls (N = 43 and 24, respectively). After T2 correction, no significant differences remained between the groups. While diffusion attenuation was not independently accounted for, these findings indicate that T2 relaxation makes a major impact on NAA concentration measures in psychotic disorders. Thus, it may be neuronal microenvironment indexed by NAA and water T2 relaxation times and not neuronal integrity indexed by NAA concentration that underlies the widely reported NAA concentration reductions in psychotic disorders.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Magnetic resonance spectroscopy (MRS); N-acetylaspartate; Psychotic disorder; Schizophrenia; T2 relaxation time

Mesh:

Substances:

Year:  2021        PMID: 34015554      PMCID: PMC8217341          DOI: 10.1016/j.schres.2021.04.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.662


  8 in total

Review 1.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

2.  Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis.

Authors:  Thomas Samuel Whitehurst; Martin Osugo; Leigh Townsend; Ekaterina Shatalina; Robert Vava; Ellis Chika Onwordi; Oliver Howes
Journal:  Neurosci Biobehav Rev       Date:  2020-10-14       Impact factor: 8.989

Review 3.  Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.

Authors:  R Grant Steen; Robert M Hamer; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

4.  Water and metabolite transverse T2 relaxation time abnormalities in the white matter in schizophrenia.

Authors:  Fei Du; Alissa Cooper; Bruce M Cohen; Perry F Renshaw; Dost Öngür
Journal:  Schizophr Res       Date:  2012-02-20       Impact factor: 4.939

5.  MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.

Authors:  Nuran Tunc-Skarka; Wolfgang Weber-Fahr; Mareen Hoerst; Andreas Meyer-Lindenberg; Mathias Zink; Gabriele Ende
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

Review 6.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

7.  1H-MRS at 4 tesla in minimally treated early schizophrenia.

Authors:  J R Bustillo; L M Rowland; P Mullins; R Jung; H Chen; C Qualls; R Hammond; W M Brooks; J Lauriello
Journal:  Mol Psychiatry       Date:  2009-11-17       Impact factor: 15.992

8.  Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques.

Authors:  Fei Du; Alissa J Cooper; Thida Thida; Ann K Shinn; Bruce M Cohen; Dost Ongür
Journal:  Biol Psychiatry       Date:  2013-04-06       Impact factor: 13.382

  8 in total
  3 in total

1.  White Matter Metabolite Relaxation and Diffusion Abnormalities in First-Episode Psychosis: A Longitudinal Study.

Authors:  Xi Chen; Xiaoying Fan; Xiaopeng Song; Margaret Gardner; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 9.306

2.  Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia.

Authors:  Fanni Krajner; Laila Hadaya; Grant McQueen; Kyra-Verena Sendt; Amy Gillespie; Alessia Avila; John Lally; Emily P Hedges; Kelly Diederen; Oliver D Howes; Gareth J Barker; David J Lythgoe; Matthew J Kempton; Philip McGuire; James H MacCabe; Alice Egerton
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-02

3.  Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla.

Authors:  Beata R Godlewska; Stephen Williams; Uzay E Emir; Chi Chen; Ann L Sharpley; Ana Jorge Goncalves; Monique I Andersson; William Clarke; Brian Angus; Philip J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2021-10-05       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.